159 related articles for article (PubMed ID: 17726578)
1. Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway.
Nakahara S; Raz A
Cancer Metastasis Rev; 2007 Dec; 26(3-4):605-10. PubMed ID: 17726578
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the nuclear import pathways of galectin-3.
Nakahara S; Oka N; Wang Y; Hogan V; Inohara H; Raz A
Cancer Res; 2006 Oct; 66(20):9995-10006. PubMed ID: 17047062
[TBL] [Abstract][Full Text] [Related]
3. Nuclear localization of Galectin-3 in transformed thyroid cells: a role in transcriptional regulation.
Paron I; Scaloni A; Pines A; Bachi A; Liu FT; Puppin C; Pandolfi M; Ledda L; Di Loreto C; Damante G; Tell G
Biochem Biophys Res Commun; 2003 Mar; 302(3):545-53. PubMed ID: 12615069
[TBL] [Abstract][Full Text] [Related]
4. Nuclear transport of galectin-3 and its therapeutic implications.
Funasaka T; Raz A; Nangia-Makker P
Semin Cancer Biol; 2014 Aug; 27():30-8. PubMed ID: 24657939
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation.
Song S; Byrd JC; Mazurek N; Liu K; Koo JS; Bresalier RS
Gastroenterology; 2005 Nov; 129(5):1581-91. PubMed ID: 16285957
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.
Ferrazzo KL; Neto MM; dos Santos E; dos Santos Pinto D; de Sousa SO
J Oral Pathol Med; 2009 Oct; 38(9):701-7. PubMed ID: 19659475
[TBL] [Abstract][Full Text] [Related]
7. On the role of galectin-3 in cancer apoptosis.
Nakahara S; Oka N; Raz A
Apoptosis; 2005 Mar; 10(2):267-75. PubMed ID: 15843888
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells.
Lin HM; Pestell RG; Raz A; Kim HR
Oncogene; 2002 Nov; 21(52):8001-10. PubMed ID: 12439750
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of galectin-3 in pituitary tumors.
Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer.
Fukumori T; Oka N; Takenaka Y; Nangia-Makker P; Elsamman E; Kasai T; Shono M; Kanayama HO; Ellerhorst J; Lotan R; Raz A
Cancer Res; 2006 Mar; 66(6):3114-9. PubMed ID: 16540661
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 in cancer.
Song L; Tang JW; Owusu L; Sun MZ; Wu J; Zhang J
Clin Chim Acta; 2014 Apr; 431():185-91. PubMed ID: 24530298
[TBL] [Abstract][Full Text] [Related]
12. Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3.
Califice S; Castronovo V; Bracke M; van den Brûle F
Oncogene; 2004 Sep; 23(45):7527-36. PubMed ID: 15326483
[TBL] [Abstract][Full Text] [Related]
13. Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma.
Wongkham S; Junking M; Wongkham C; Sripa B; Chur-In S; Araki N
Cancer Sci; 2009 Nov; 100(11):2077-84. PubMed ID: 19723119
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3, a novel binding partner of beta-catenin.
Shimura T; Takenaka Y; Tsutsumi S; Hogan V; Kikuchi A; Raz A
Cancer Res; 2004 Sep; 64(18):6363-7. PubMed ID: 15374939
[TBL] [Abstract][Full Text] [Related]
15. Transport of galectin-3 between the nucleus and cytoplasm. I. Conditions and signals for nuclear import.
Davidson PJ; Li SY; Lohse AG; Vandergaast R; Verde E; Pearson A; Patterson RJ; Wang JL; Arnoys EJ
Glycobiology; 2006 Jul; 16(7):602-11. PubMed ID: 16473835
[TBL] [Abstract][Full Text] [Related]
16. Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression.
Wang L; Guo XL
Biomed Pharmacother; 2016 Mar; 78():165-171. PubMed ID: 26898438
[TBL] [Abstract][Full Text] [Related]
17. Role of galectin-3 in autoimmune and non-autoimmune nephropathies.
Saccon F; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
Autoimmun Rev; 2017 Jan; 16(1):34-47. PubMed ID: 27666815
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.
Zheng D; Hu Z; He F; Gao C; Xu L; Zou H; Wu Z; Jiang X; Wang J
Oncol Rep; 2014 Jul; 32(1):411-8. PubMed ID: 24807674
[TBL] [Abstract][Full Text] [Related]
19. HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc.
Zeng Y; Danielson KG; Albert TJ; Shapiro IM; Risbud MV
J Bone Miner Res; 2007 Dec; 22(12):1851-61. PubMed ID: 17592963
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 and cancer (Review).
Califice S; Castronovo V; Van Den Brûle F
Int J Oncol; 2004 Oct; 25(4):983-92. PubMed ID: 15375548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
